We do not have any brand version of this medication at the moment
Description
What is Harvoni (Ledipasvir/Sofosbuvir)?
Considered as an antiretroviral drug, Harvoni is a medicine taken for a lifelong hepatitis C treatment. Its main components are known to be Ledipasvir and Sofosbuvir. The medication is prescribed for individuals of different ages, including adults and children. It is also available as Hepcinat LP and Myhep Lvir.
How does Harvoni work?
Since Harvoni is a mixture of two different medications (Ledipasvir & Sofosbuvir), it has provided a wide range of benefits to patients the hepatitis C. Both of these medications are components of distinct groups of medicines.
Ledipasvir - HCV NS5A inhibitor
Sofosbuvir - HCV NS5B polymerase inhibitor
Apart from its inhibiting action towards the hepatitis C virus, it also encourages the body’s immune system to operate more competently. It reinforces our body’s immunity against viral infection.
Dosage
Harvoni’s dosage depends on several factors the doctor must consider. They include:
Age of the individuals with the medical problem
Weight
Other medical concerns aside from chronic hepatitis C
Medical history
Adult Dosage (35 kgs)
90 mg or 400 mg – consume once a day
Children Dosage (17 kgs – 35 kgs)
45 mg or 200 mg – consume once a day
How to take it?
Harvoni can be taken with or without a meal. During the medical treatment, the patient must comply with the prescription given by his/her healthcare specialist. This is the only way to keep the dosage and the treatment on the right track. Avoid acquiring more infections by following the right orders. The added infection will only trigger other health complications.
Harvoni Side Effects
From mild to severe, these medications’ side effects are manageable. Nevertheless, if these continue to affect you, especially in your daily activities, medical care should be administered urgently.
Maecenas quis purus eget sem ultrices auctor vel ut quam. Mauris scelerisque consectetur sem, id commodo libero tincidunt ut. Nulla laoreet tortor vitae augue feugiat rhoncus.